Pulmonary Hypertension: Advances in Risk Assessment and Emerging Procedures

Affiliations

Comment

Micheal L'Heureux et al. Am J Respir Crit Care Med. 2020.

. 2020 Sep 1;202(5):745-747.

doi: 10.1164/rccm.201912-2484RR.

¹ Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, Virginia.

No abstract available

Comment on

Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study.
Zhang H, Zhang J, Chen M, Xie DJ, Kan J, Yu W, Li XB, Xu T, Gu Y, Dong J, Gu H, Han Y, Chen SL. Zhang H, et al. JACC Cardiovasc Interv. 2019 Feb 11;12(3):274-284. doi: 10.1016/j.jcin.2018.09.021. Epub 2018 Oct 23. JACC Cardiovasc Interv. 2019. PMID: 30732732 Clinical Trial.
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE, McGoon MD, Pasta DJ, Selej M, Burger CD, Frantz RP. Benza RL, et al. Chest. 2019 Aug;156(2):323-337. doi: 10.1016/j.chest.2019.02.004. Epub 2019 Feb 14. Chest. 2019. PMID: 30772387
French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
Brenot P, Jaïs X, Taniguchi Y, Garcia Alonso C, Gerardin B, Mussot S, Mercier O, Fabre D, Parent F, Jevnikar M, Montani D, Savale L, Sitbon O, Fadel E, Humbert M, Simonneau G. Brenot P, et al. Eur Respir J. 2019 May 18;53(5):1802095. doi: 10.1183/13993003.02095-2018. Print 2019 May. Eur Respir J. 2019. PMID: 31023842 Free PMC article. Clinical Trial.